in

Galectin Therapeutics Inc. CEO & President & Chief Medical Officer Peter G. Traber Resigned

Galectin Names Shlevin as New CEO; Traber Resigns

Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that Harold H. Shlevin, Ph.D., currently the Company’s Chief Operating Officer (COO), has been appointed Chief Executive Officer (CEO) and President to succeed Peter G. Traber, M.D., who has tendered his resignation as President, CEO and Chief Medical Officer.


Name: Peter G. Traber

Continent: North America

Country: USA

Company: Galectin Therapeutics Inc.

Branch: Healthcare

Position: CEO & President & Chief Medical Officer

Reason: Resigned

Announcement Date: June 12, 2018, 10:00pm

Resignation Date: June 12, 2018, 10:00pm

Source 1: https://awesomecapital.wordpress.com/2018/06/13/galectin-names-shlevin-as-new-ceo-traber-resigns/


Add your submission

Image Video Audio Text Embed

This field is required

Drop Images Here

or

You don't have javascript enabled. Media upload is not possible.

Get image from URL

Maximum upload file size: 10 MB.

Processing...

This field is required

Drop Video Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://www.youtube.com/watch?v=WwoKkq685Hk

Add

Supported services:

Maximum upload file size: 20 MB.

Processing...

This field is required

Drop Audio Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://soundcloud.com/community/fellowship-wrapup

Add

Supported services:

Maximum upload file size: 150 MB.

Processing...

This field is required

e.g.: https://www.youtube.com/watch?v=DWYrcnehito

Supported services:

Processing...

Report

What do you think?

Leave a Reply